Cong ministers are corrupt... Cong ministers will join BJP: Nalin Kateel

Mangaluru, Feb 10: Sandeep Malani has been of lately winning back to back awards at various events and film festivals. Being an actor, he has won 3 Best Actor awards (2 for his gripping performance in the Kannada feature film, Mookavismitha, directed by Gurudutt Sreekanth and one award for his multi faceted performance in the short film, Nishyabda Nishi directed by his son Silver). These awards were honored at the Indian Cine Film Festival in Mumbai and Karunadu Kannada Rathna Award in Bengaluru.

He also won an award for his woman empowerment film, Sulige Sikkidaaga in Pune, while his musical documentary on Sridevi titled SrideviBaaz won him two awards at Pune and Kolhapur International film festivals. His other short film on transgender Mamta (Maternal Love) won the Audience Awards in USA.

Very recently he was honored by the Filmaholic Foundation in Bengaluru for being a successful short film maker with two Kannada films Jo Jo Laali and Sulige Sikkidaaga, both featuring award winning actress Kalpana Pandit, winning multiple awards and making news at International Film Festivals. This honor was given at the Karnataka Youth International Short Film Festival.

With donning so many feathers of awards in his hat, he recently bagged the most prestigious one; that being receiving the Award for Best Feature Film shot on Mobile for his film ‘Maa – Yeh CineMaa Hai’ shot on iPhone at the 1st ever IMFF India (International Mobile Film Festival India 2020) held at World Trade Center, Mumbai on 8th February.

With a whole lot short films in the category and barely few feature films in the Feature Film Category, Malani verged out to be the winner as his Hindi film was a complete family entertainer that of 5 songs, sentiment value, and a wholesome entertainer with 100 artists working in the film that consists of stage and television actors, newcomers, models and common people. The film starred Sandeep’s family members playing important roles. His mother, Meena Malani (playing the title role), wife Reshma Malani (playing one of the lead actress) and son Silver Malani (playing an important character). The cast includes Mahesh Dulam, Anita Dulam, Ranjeet Jha, Bharath Lakshmikanth, Mahendra Pandey, Vishal Digani, Akash Hora, Shuba Raksha, Sanjukta Ghosh, Sharanya Kaur, Varsha Acharya, Kkewal Sharma, Anant Joshi, Vivek Punjabi, Valerian Menezes, Nigel Pereira. Veteran actresses Sarojini Shetty, Deepali Khambadkone, Vinny Fernandes also features in the film while Kalpana Pandit, Sudha Chandran, Sonal Monteiro, Adaa Khan and others give a social message on mother, womanhood and empowerment.  The film has been jointly produced by RKJ Film Productions, The Studio Agency and Malani Talkies.

Mangaluru, Apr 3: The laboratory at District Wenlock Hospital has initiated trial for Covid 19 testing, close on the heels of receiving permission from state government.

Doctors, elected representatives and stakeholders had repeatedly demanded that a laboratory should be set up in the port city. Without the lab, the samples were sent either to Shivamogga or to Bengaluru for testing. When Heath Minister Sriramulu had visited Mangaluru on March 17, he had promised a lab in the city for testing of the samples.

Accordingly, the government gave permission for starting the laboratory at Wenlock Hospital. The process of registering the lab with Indian Council for Medical Research (ICMR) will be completed shortly. The laboratory will be fully operational only after it is registered.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.